
Oncologist


No OPD information available
Melanoma
Prostate Cancer
Melanoma of the Eye
Metastatic Uveal Melanoma
Uveal Melanoma
Cerebral Hypoxia
Prostatectomy
Adrenal Cancer
Adrenocortical Carcinoma
Bladder Cancer
Bone Tumor
Breast Cancer
Dry Mouth
Eosinophilic Fasciitis
Head and Neck Squamous Cell Carcinoma (HNSCC)
Lung Cancer
Lung Metastases
Neuroendocrine Tumor
Non-Small Cell Lung Cancer (NSCLC)
Pheochromocytoma
Renal Cell Carcinoma (RCC)
Retinal Artery Occlusion
Sarcoidosis
Anthony M. Joshua is a male doctor who helps patients with many different health problems like melanoma, prostate cancer, eye melanoma, and more. He is skilled in treating various conditions like cerebral hypoxia, bladder cancer, lung cancer, and others.
Dr. Joshua is known for his special skills in performing surgeries like prostatectomy and treating rare conditions such as adrenal cancer and eosinophilic fasciitis. He uses advanced treatments to help patients fight diseases like bone tumors, breast cancer, and neuroendocrine tumors.
Patients trust Dr. Joshua because he communicates well with them, explaining their conditions in simple terms and answering their questions kindly. He listens to their concerns and involves them in making decisions about their treatment.
Dr. Joshua stays updated with the latest medical knowledge and research to provide the best care for his patients. He attends conferences, reads medical journals, and collaborates with other experts to learn about new treatments and technologies.
In his work, Dr. Joshua collaborates closely with his colleagues and other medical professionals to ensure that patients receive comprehensive care. He values teamwork and shares his knowledge and expertise with others to improve patient outcomes.
Dr. Joshua's dedication and expertise have made a positive impact on many patients' lives. His research on personalized cancer medicine has contributed to advancing precision oncology, offering hope to patients with challenging conditions.
One of Dr. Joshua's notable publications is "Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients." This article highlights his commitment to improving cancer care through personalized treatment approaches.
Additionally, Dr. Joshua has been involved in clinical trials like the "Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors." Although this trial was terminated, his participation demonstrates his dedication to exploring innovative treatments for cancer.
Overall, Dr. Anthony M. Joshua is a compassionate and skilled doctor who is committed to providing high-quality care to his patients and advancing medical knowledge to improve outcomes for those fighting serious illnesses.
Enrollment Status: Terminated
Published: March 10, 2025
Intervention Type: Drug
Study Drug: Ladiratuzumab Vedotin
Study Phase: Phase 2
